{"filing":{"accession_number":"0001193125-26-251994","cik":"0001544227","ticker":"TPST","company_name":"Tempest Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-02","report_date":null,"primary_document":"d105562d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526251994/d105562d8k.htm"},"events":[{"id":7426,"run_id":6526,"accession_number":"0001193125-26-251994","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Tempest Therapeutics entered into a warrant exercise and inducement offer agreement on May 28, 2026, resulting in the issuance of unregistered securities including the exercise of existing warrants for approximately $2.0 million in gross proceeds at a reduced exercise price of $1.73 per share, and the issuance of new unregistered warrants to purchase 2,344,828 shares plus placement agent warrants to purchase 82,069 shares, all offered and sold under Section 4(a)(2) exemption.","company_name":"Tempest Therapeutics, Inc.","ticker":"TPST","filing_date":"2026-06-02","form":"8-K","submitted_at":null,"items":[{"id":3523,"accession_number":"0001193125-26-251994","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Tempest Therapeutics entered into a warrant exercise and inducement offer agreement on May 28, 2026, resulting in the issuance of unregistered securities: (1) exercise of existing warrants for ~$2.0 million in gross proceeds at a reduced exercise price of $1.73 per share, and (2) issuance of new unregistered warrants to purchase 2,344,828 shares plus placement agent warrants to purchase 82,069 shares. The securities were offered and sold under Section 4(a)(2) exemption and have not been registered under the Securities Act, constituting a dilutive private placement that would materially affect shareholder equity and voting power.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:13:41.864678+00:00","company_name":"","ticker":null,"filing_date":""},{"id":3524,"accession_number":"0001193125-26-251994","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 explicitly addresses \"Unregistered Sales of Equity Securities\" and incorporates details from Item 1.01, which typically covers material acquisitions or transactions. The disclosure of unregistered equity issuances is a classic dilutive_issuance event, particularly material for small- and mid-cap companies raising capital through private placements or similar mechanisms.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:13:41.864678+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3523,"accession_number":"0001193125-26-251994","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Tempest Therapeutics entered into a warrant exercise and inducement offer agreement on May 28, 2026, resulting in the issuance of unregistered securities: (1) exercise of existing warrants for ~$2.0 million in gross proceeds at a reduced exercise price of $1.73 per share, and (2) issuance of new unregistered warrants to purchase 2,344,828 shares plus placement agent warrants to purchase 82,069 shares. The securities were offered and sold under Section 4(a)(2) exemption and have not been registered under the Securities Act, constituting a dilutive private placement that would materially affect shareholder equity and voting power.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:13:41.864678+00:00","company_name":"Tempest Therapeutics, Inc.","ticker":"TPST","filing_date":"2026-06-02"},{"id":3524,"accession_number":"0001193125-26-251994","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 explicitly addresses \"Unregistered Sales of Equity Securities\" and incorporates details from Item 1.01, which typically covers material acquisitions or transactions. The disclosure of unregistered equity issuances is a classic dilutive_issuance event, particularly material for small- and mid-cap companies raising capital through private placements or similar mechanisms.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:13:41.864678+00:00","company_name":"Tempest Therapeutics, Inc.","ticker":"TPST","filing_date":"2026-06-02"}]}